Sara Posadas-Cantera

Multi-omics analysis of naïve B cells of patients harboring the C104R mutation in TACI

E. Ballestar, R. Geiger, H. Eibel, 2022, Frontiers in Immunology.

The ABACHAI clinical trial protocol: Safety and efficacy of abatacept (s.c.) in patients with CTLA-4 insufficiency or LRBA deficiency: A non controlled phase 2 clinical trial

I. Dybedal, K. Warnatz, B. Grimbacher, 2022, Contemporary clinical trials communications.

Detrimental NFKB1 missense variants affecting the Rel-homology domain of p105/p50

J. Walter, J. Church, M. Varjosalo, 2022, Frontiers in Immunology.

Integrated Multi-omics Analyses of NFKB1 patients B cells points towards an up regulation of NF-κB network inhibitors

E. Ballestar, C. Bock, R. Geiger, 2022, bioRxiv.

There is no gene for CVID - novel monogenetic causes for primary antibody deficiency.

B. Grimbacher, Andrés Caballero-Oteyza, N. Ramirez, 2021, Current opinion in immunology.

Do common infections trigger disease-onset or -severity in CTLA-4 insufficiency?

J. Litzman, Hanns-Martin Lorenz, G. Häcker, 2022, Frontiers in Immunology.

Functional Relevance of CTLA4 Variants: an Upgraded Approach to Assess CTLA4-Dependent Transendocytosis by Flow Cytometry.

B. Grimbacher, Elena Sindram, Annemarie Gabrysch, 2023, Journal of clinical immunology.